nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfaphenazole—CYP2B6—Cisplatin—bone cancer	0.318	0.397	CbGbCtD
Sulfaphenazole—CYP2B6—Doxorubicin—bone cancer	0.213	0.266	CbGbCtD
Sulfaphenazole—CYP2C9—Cisplatin—bone cancer	0.168	0.21	CbGbCtD
Sulfaphenazole—CYP2D6—Doxorubicin—bone cancer	0.103	0.128	CbGbCtD
Sulfaphenazole—CYP2A6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0094	0.0556	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00759	0.0449	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00642	0.038	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Liver X Receptor Pathway—CYP3A4—bone cancer	0.00638	0.0377	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.00614	0.0363	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00543	0.0321	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.0053	0.0313	CbGpPWpGaD
Sulfaphenazole—Celecoxib—CYP3A4—bone cancer	0.00529	0.189	CrCbGaD
Sulfaphenazole—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00527	0.0312	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00523	0.0309	CbGpPWpGaD
Sulfaphenazole—Celecoxib—PTGS2—bone cancer	0.00518	0.185	CrCbGaD
Sulfaphenazole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.005	0.0296	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Xenobiotics—CYP3A4—bone cancer	0.00454	0.0268	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00436	0.0258	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.0041	0.0243	CbGpPWpGaD
Sulfaphenazole—Sulfadiazine—CYP3A4—bone cancer	0.00383	0.137	CrCbGaD
Sulfaphenazole—CYP2B6—Xenobiotics—CYP3A4—bone cancer	0.00366	0.0217	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Fluoropyrimidine Activity—DHFR—bone cancer	0.00359	0.0212	CbGpPWpGaD
Sulfaphenazole—Sulfasalazine—PTGS2—bone cancer	0.00351	0.125	CrCbGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—CYP4V2—bone cancer	0.00327	0.0193	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00312	0.0184	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Xenobiotics—CYP3A4—bone cancer	0.0031	0.0183	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.00304	0.018	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Tamoxifen metabolism—CYP3A4—bone cancer	0.00298	0.0176	CbGpPWpGaD
Sulfaphenazole—Sulfamethoxazole—CYP3A4—bone cancer	0.00297	0.106	CrCbGaD
Sulfaphenazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.00282	0.0167	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—CYP4V2—bone cancer	0.00276	0.0164	CbGpPWpGaD
Sulfaphenazole—Sulfanilamide—CYP3A4—bone cancer	0.0026	0.0931	CrCbGaD
Sulfaphenazole—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.00254	0.0151	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.00252	0.0149	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00251	0.0149	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.00245	0.0145	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.00243	0.0144	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.0024	0.0142	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00239	0.0142	CbGpPWpGaD
Sulfaphenazole—Dapsone—CYP3A4—bone cancer	0.00232	0.083	CrCbGaD
Sulfaphenazole—Dapsone—PTGS2—bone cancer	0.00227	0.0813	CrCbGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.00227	0.0134	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.00225	0.0133	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.00217	0.0128	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00188	0.0111	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00186	0.011	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00173	0.0102	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.00165	0.00976	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00153	0.00904	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00152	0.00899	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.0015	0.00888	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00129	0.00761	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00127	0.00751	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00123	0.00729	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00106	0.00625	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00105	0.0062	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00104	0.00617	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00104	0.00617	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00103	0.00612	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000857	0.00507	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000849	0.00502	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—CYP3A4—bone cancer	0.000811	0.0048	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	0.000802	0.00474	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—GSTP1—bone cancer	0.000791	0.00468	CbGpPWpGaD
Sulfaphenazole—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	0.000791	0.00468	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Biological oxidations—GSTP1—bone cancer	0.000694	0.00411	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.00066	0.0039	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—CYP3A4—bone cancer	0.000655	0.00387	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	0.000646	0.00382	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Biological oxidations—GSTP1—bone cancer	0.00056	0.00331	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000554	0.00328	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	0.000552	0.00327	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	0.000547	0.00323	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	0.000537	0.00318	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—NDUFA12—bone cancer	0.000486	0.00288	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Biological oxidations—GSTP1—bone cancer	0.000474	0.0028	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	0.000468	0.00277	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000455	0.00269	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—CYP3A4—bone cancer	0.000451	0.00267	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000449	0.00266	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	0.000445	0.00263	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—NT5C3A—bone cancer	0.000403	0.00238	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—NDUFA12—bone cancer	0.000392	0.00232	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000389	0.0023	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Biological oxidations—GSTP1—bone cancer	0.000386	0.00228	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000384	0.00227	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	0.000381	0.00225	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—NDUFA12—bone cancer	0.000332	0.00197	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—NT5C3A—bone cancer	0.000325	0.00192	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—NT5C3A—bone cancer	0.000275	0.00163	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—NDUFA12—bone cancer	0.000273	0.00161	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—NDUFA12—bone cancer	0.00027	0.0016	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—NT5C3A—bone cancer	0.000226	0.00134	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—NT5C3A—bone cancer	0.000224	0.00133	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—ENO2—bone cancer	0.000177	0.00104	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—DHFR—bone cancer	0.000164	0.000969	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GNA11—bone cancer	0.000153	0.000906	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—ENO2—bone cancer	0.000142	0.000843	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—CYP3A4—bone cancer	0.000139	0.000821	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—DHFR—bone cancer	0.000132	0.000782	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GNA11—bone cancer	0.000124	0.000731	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—ENO2—bone cancer	0.000121	0.000713	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—GSTP1—bone cancer	0.000119	0.000702	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—CYP3A4—bone cancer	0.000112	0.000662	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—DHFR—bone cancer	0.000112	0.000662	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GNA11—bone cancer	0.000105	0.000619	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—ENO2—bone cancer	9.9e-05	0.000586	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—ENO2—bone cancer	9.81e-05	0.000581	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—GSTP1—bone cancer	9.58e-05	0.000567	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—CYP3A4—bone cancer	9.48e-05	0.000561	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.43e-05	0.000558	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—DHFR—bone cancer	9.18e-05	0.000543	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—DHFR—bone cancer	9.11e-05	0.000539	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GNA11—bone cancer	8.58e-05	0.000508	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GNA11—bone cancer	8.51e-05	0.000503	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—GSTP1—bone cancer	8.11e-05	0.00048	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—CYP3A4—bone cancer	7.78e-05	0.00046	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—CYP3A4—bone cancer	7.71e-05	0.000456	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.68e-05	0.000454	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—GSTP1—bone cancer	6.66e-05	0.000394	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—GSTP1—bone cancer	6.6e-05	0.00039	CbGpPWpGaD
Sulfaphenazole—CYP2A6—Metabolism—PTGS2—bone cancer	6.15e-05	0.000364	CbGpPWpGaD
Sulfaphenazole—CYP2B6—Metabolism—PTGS2—bone cancer	4.96e-05	0.000293	CbGpPWpGaD
Sulfaphenazole—CYP2C8—Metabolism—PTGS2—bone cancer	4.2e-05	0.000248	CbGpPWpGaD
Sulfaphenazole—CYP2D6—Metabolism—PTGS2—bone cancer	3.45e-05	0.000204	CbGpPWpGaD
Sulfaphenazole—CYP2C9—Metabolism—PTGS2—bone cancer	3.42e-05	0.000202	CbGpPWpGaD
